Skip to main content
Premium Trial:

Request an Annual Quote

Bioscreen to Distribute Labcyte Systems in India

NEW YORK (GenomeWeb News) – Bioscreen Instruments will distribute Labcyte’s acoustic liquid transfer systems in India, Labcyte said today.

The distribution agreement will help “further broaden our existing user base in the pharmaceutical industry and the contract research organizations that service them,” Labcyte’s VP of Sales, Marketing, and Service, Stephen Bates, said in a statement.

Chennai, India-based Bioscreen will provide the Labcyte technology for compound management and high-throughput and secondary screening research, Bates said.

Bioscreen is a life sciences provider focused on providing drug discovery, genomics, and proteomics technologies.

Nick Samaras, Labcyte’s Asia-Pacific Managing Director, said that the firm's platform also may be used in areas such as imaging mass spectrometry, array formation, compound microencapsulation, particle production, proteomics research, and cell-based biology.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.